• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
MeiraGTx released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 410K (forecast USD 6.966M), actual EPS USD -0.624 (forecast USD -0.49)
04:00
MeiraGTx released FY2025 9 Months Earnings on November 13 (EST), with actual revenue of USD 6.027 M and EPS of USD -1.6113
04:00
Nov13
MeiraGTx Reports Q3 Revenue Below Estimates
13:01
Nov10
MeiraGTx Updates Late-Stage Clinical Pipeline and Manufacturing Capabilities
12:34
MeiraGTx Holdings plc and Eli Lilly Enter into Strategic Collaboration in Ophthalmic Gene Therapy
12:01
Aug15
MeiraGTx released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 3.691 M (forecast USD 6.484 M), actual EPS USD -0.4814 (forecast USD -0.4675)
03:00

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 410 K, Net Income -50.51 M, EPS -0.624

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.691 M, Net Income -38.8 M, EPS -0.4814

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.926 M, Net Income -39.98 M, EPS -0.5058

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
10.580
+93.77%
+5.120
AEHL
2.180
+92.92%
+1.050
AFJK
82.580
+89.19%
+38.930
PFSA
0.1218
+78.33%
+0.053
DLXY
1.410
+67.86%
+0.570
ULY
2.760
+52.49%
+0.950
MENS
4.220
+51.80%
+1.440
CETX
2.980
+41.23%
+0.870
DAIC
0.5500
+39.06%
+0.154
ONTF
8.060
+37.54%
+2.200
View More